These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6259597)

  • 21. [Pharmacokinetics and tolerance of Cefazedone compared with Cefazoline (author's transl)].
    Hitzenberger G; Jaschek I
    Wien Med Wochenschr; 1980 Feb; 130(3):135-42. PubMed ID: 7368759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Concentration of cefoperazone in various tissues of the urogenital system (author's transl)].
    Schalkhäuser K; Adam D
    Arzneimittelforschung; 1981; 31(10):1770-2. PubMed ID: 6459099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical experience of cefotaxime (author's transl)].
    Portier H; Carbon C; Boussougant Y; Destaing F
    Nouv Presse Med; 1981 Feb; 10(8):607-11. PubMed ID: 6259603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study on the interstitial passage of cefuroxime, cefoxitin, cefotaxime and cefoperazone in man by the suction skin blister method.
    Frongillo RF; Galuppo L; Moretti A
    Boll Ist Sieroter Milan; 1983 Nov; 62(5):412-6. PubMed ID: 6322818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical evaluation of cefotaxime at various dosage levels in urinary tract infections (author's transl)].
    Guibert J; Acar JF; Justin C; Kitzis MD
    Nouv Presse Med; 1981 Feb; 10(8):625-7. PubMed ID: 6259607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cefotaxime in childhood infections (author's transl)].
    Garnier JM; Giraud F
    Nouv Presse Med; 1981 Feb; 10(8):629-33. PubMed ID: 6259608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limiting cefotaxime pediatric dosing to adult standards: a pharmacokinetic simulation study.
    Dulaney Lopez AM; Rodriguez JC; Lopez-Samblas AM; Estes KS
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):269-74. PubMed ID: 10395117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cefotaxime in digestive tract infections (author's transl)].
    Paris J; Paris JC; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):647-9. PubMed ID: 6259611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis.
    Chodos J; Francke EL; Saltzman M; Neu HC
    Ther Drug Monit; 1981; 3(1):71-4. PubMed ID: 6262952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum levels of doxycycline during and after thoracic operation.
    Silvola H; Tourunen E; Mattila MJ
    Ann Clin Res; 1981 Feb; 13(1):22-5. PubMed ID: 7247322
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy.
    Lee LJ; Sha X; Gotfried MH; Howard JR; Dix RK; Fish DN
    Pharmacotherapy; 1998; 18(1):35-41. PubMed ID: 9469679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The penetration of novel intravenous cephalosporins into the lung.
    Baldwin DR
    J Chemother; 1996 Feb; 8 Suppl 2():71-82. PubMed ID: 8738849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The use of cefotaxime against infections (author's transl)].
    Lepeu G; Bertrand A; Armengaud M; Aubertin J
    Nouv Presse Med; 1981 Feb; 10(8):594-7. PubMed ID: 6259600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Combined cefotaxime-amikacin treatment of infectious episodes in acute leukaemia patients with therapeutically-induced bone marrow aplasia (author's transl)].
    Guy H; Chavanet P; Portier H; Kazmierczak A; Cortet P
    Nouv Presse Med; 1981 Feb; 10(8):654-6. PubMed ID: 6259613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of cefotaxime and penetration in sputum, bone, and prostatic tissue.
    Braga PC; Pozzato C; Cedrini C; Fraschini F; Scarpazza G; Scaglione F; Gagliardi V; Apicella F; Manganelli V; Paiola G
    Clin Ther; 1982; 5(1):69-78. PubMed ID: 6290066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone and serum concentrations of five cephalosporin drugs. Relevance to prophylaxis and treatment in orthopedic surgery.
    Williams DN; Gustilo RB; Beverly R; Kind AC
    Clin Orthop Relat Res; 1983 Oct; (179):253-65. PubMed ID: 6617025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The passage of mezlocillin into the cerebrospinal fluid. An experimental study in dogs with normal meninges and with Staphylococcus aureus meningitis (author's transl)].
    Armengaud M; Massip P; Tran Van Tho A; Chan Lai Wane L
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):368-72. PubMed ID: 6460978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cefotaxime in the treatment of purulent meningitis in children (author's transl)].
    Borderon JC; Despert F; Santini JJ; Laugier J; Grenier B; Boulard P
    Nouv Presse Med; 1981 Feb; 10(8):634-8. PubMed ID: 6259609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.